Allergy Immunotherapy, a Preventive Treatment for Allergic Reactions
Allergy
Immunotherapy is a medical therapy for seasonal allergic reactions, such as
pollen and dust mites. It is also effective in treating serious allergens such
as tree sap, mold, mold spores, animal dander, and other substances that can
trigger an allergic reaction in allergy sufferers. Allergic asthma is a chronic
condition and if not managed properly can lead to death. Allergic Asthma
Therapeutics is designed to target the specific allergen that can cause
problems and thus, makes it easier to manage asthma attacks.
Allergy
immunotherapy involves exposing individuals to larger doses of the allergic
substance to alter the body's response to that allergen. The treatment can be
given in the form of injections, patches, or oral medication. A patch is used
by placing a small amount of the allergenic substance on the skin to provide a
temporary barrier to the allergenic substance and in the oral medication, the
allergenic substance is taken orally and the body is exposed to the allergen
repeatedly. This process allows the body to develop a tolerance for the
allergen. There are several benefits of this therapy, including relief from
seasonal allergies that can lead to more serious diseases such as allergic
rhinitis and asthma. Moreover, three main types of allergy immunotherapy are
currently in use, such as oral allergy immunotherapy, subcutaneous allergy
immunotherapy (SCIT), and sublingual allergy immunotherapy (SLIT). Of these,
SLIT treats allergies with tablets rather than injections.
Allergic rhinitis
and asthma are some of the most common inhaled allergies that affect the majority
of the population across the globe. For instance, According to the Centers for
Disease Control and Prevention (CDC), more than 25 million Americans have
asthma. Moreover, according to the European Academy of Allergy and Clinical
Immunology, over 150 million Europeans suffer from chronic allergic diseases
and around 50% of Europeans are expected to have at least one form of allergy
by 2025.
Comments
Post a Comment